Cost-effectiveness of aromatase inhibitor co-treatment for controlled ovarian stimulation

Author： Bedaiwy Mohamed A. Forman Rachel Mousa Noha A. Al Inany Hesham G. Casper Robert F.

ISSN： 1460-2350

Source： Human Reproduction, Vol.21, Iss.11, 2006-11, pp. : 2838-2844

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Short-term androgen priming by use of aromatase inhibitor and hCG before controlled ovarian stimulation for IVF. A randomized controlled trial

By Lossl K. Andersen C. Yding Loft A. Freiesleben N.L.C. Bangsbll S. Andersen A. Nyboe

Human Reproduction, Vol. 23, Iss. 8, 2008-08 ,pp. : 1820-1829

Oxford University Press

Access to resources Recommend Favorite

Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment

By Devroey Paul Aboulghar Mohamed Garcia-Velasco Juan Griesinger Georg Humaidan Peter Kolibianakis Efstratios Ledger William Toms Candido Fauser Bart C.J.M.

Human Reproduction, Vol. 24, Iss. 4, 2009-04 ,pp. : 764-774

Oxford University Press

Access to resources Recommend Favorite

Infertility. Early resort to ovarian stimulation improves the cost-effectiveness of a donor insemination programme

By Lashen H. Afnan M.

Human Reproduction, Vol. 14, Iss. 8, 1999-08 ,pp. : 1983-1988

Oxford University Press

Access to resources Recommend Favorite

Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility

Human Reproduction, Vol. 18, Iss. 8, 2003-08 ,pp. : 1588-1597

Oxford University Press

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Thrombolytic Treatment for Stroke

Cerebrovascular Diseases, Vol. 20, Iss. 3, 2005-09 ,pp. : 193-200

Karger

Access to resources Recommend Favorite